1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:MD and FA of TDLs and high-grade gliomasa
Region/Metrics TDLs High-Grade Gliomas P Value 95% CI Nonenhancing portion FA 0.06 ± 0.02 0.07 ± 0.03 .526 −0.035–0.018 MD 1.702 ± 0.414 1.806 ± 0.578 .663 −0.597–0.388 Enhancing portion FA 0.18 ± 0.05 0.12 ± 0.01 .004 0.020-.088 MD 0.887 ± 0.265 1.237 ± 0.124 .001 −0.528–0.172 Perilesional edema FA 0.11 ± 0.01 0.17 ± 0.03 .001 −0.091–0.028 MD 1.411 ± 0.262 1.270 ± 0.121 .158 −0.062–0.346
Note:—CI indicates confidence interval.
↵a Data are the mean. Unit is × 10−3 mm2/s for MD values.